Phase-3 malaria vaccine trial begins in Kenya
Kenya is part of the collaborative Phase III R21/Matrix-M Malaria Vaccine Trial, which is evaluating a promising candidate malaria vaccine developed with the University of Oxford with the Serum Institute of
Read on